Our mission is to radically improve survival of women with low-grade serous ovarian cancer through research and to provide good information to enable and empower them to make informed decisions about their care.
Low-grade serous ovarian cancer (LGSOC) is a difficult-to-treat and under-researched ovarian cancer that disproportionately affects younger women.
The Low-Grade Serous Ovarian Cancer Initiative is dedicated to advancing research into LGSOC. In partnership with the BC Cancer Foundation, we’ve created a pathway for people to donate specifically to LGSOC research, helping to support the work of Dr. Mark Carey's laboratory.
Dr. Carey leads one of the largest LGSOC research laboratories in the world and is recognised as a global leader in efforts to improve LGSOC survival outcomes.
Donations and funds raised through this page are administered by the BC Cancer Foundation on behalf of the LGSOC Initiative. 100% of the contributions support LGSOC research in Canada.
Visit lgsoc.org/canada to learn more.